Wall Street analysts expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to post earnings per share of $0.18 for the current quarter, according to Zacks. Ten analysts have issued estimates for Allscripts Healthcare Solutions’ earnings, with the highest EPS estimate coming in at $0.20 and the lowest estimate coming in at $0.17. Allscripts Healthcare Solutions posted earnings of $0.14 per share in the same quarter last year, which suggests a positive year over year growth rate of 28.6%. The firm is expected to announce its next earnings report on Thursday, February 15th.

According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $0.61 per share for the current financial year, with EPS estimates ranging from $0.60 to $0.63. For the next financial year, analysts expect that the company will post earnings of $0.75 per share, with EPS estimates ranging from $0.67 to $0.80. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that follow Allscripts Healthcare Solutions.

A number of research analysts recently commented on MDRX shares. Maxim Group restated a “buy” rating and issued a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Friday, August 4th. Robert W. Baird restated a “buy” rating and issued a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. Jefferies Group LLC set a $17.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research report on Friday, August 25th. Dougherty & Co restated a “buy” rating and issued a $16.00 price target (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 3rd. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $17.00 price target on shares of Allscripts Healthcare Solutions in a research report on Wednesday, September 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $15.06.

Shares of Allscripts Healthcare Solutions (MDRX) traded up $0.33 during midday trading on Friday, hitting $13.59. The company had a trading volume of 3,413,806 shares, compared to its average volume of 2,347,223. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20. Allscripts Healthcare Solutions has a 52 week low of $10.19 and a 52 week high of $14.45. The company has a market capitalization of $2,395.83, a PE ratio of 30.84, a P/E/G ratio of 2.36 and a beta of 1.35.

COPYRIGHT VIOLATION NOTICE: “Zacks: Analysts Expect Allscripts Healthcare Solutions, Inc. (MDRX) to Announce $0.18 Earnings Per Share” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://theolympiareport.com/2017/11/20/zacks-analysts-expect-allscripts-healthcare-solutions-inc-mdrx-to-announce-0-18-earnings-per-share.html.

In other news, CEO Paul Black sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $13.52, for a total transaction of $202,800.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the sale, the executive vice president now directly owns 196,607 shares in the company, valued at $2,658,126.64. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock worth $473,800 over the last ninety days. 0.91% of the stock is currently owned by insiders.

Several hedge funds have recently made changes to their positions in MDRX. OppenheimerFunds Inc. boosted its stake in shares of Allscripts Healthcare Solutions by 9.4% during the first quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock valued at $399,000 after purchasing an additional 2,701 shares in the last quarter. KCG Holdings Inc. boosted its stake in shares of Allscripts Healthcare Solutions by 12.6% during the first quarter. KCG Holdings Inc. now owns 19,805 shares of the software maker’s stock valued at $251,000 after purchasing an additional 2,213 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of Allscripts Healthcare Solutions by 6.9% during the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock valued at $135,000 after purchasing an additional 689 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of Allscripts Healthcare Solutions by 4.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 68,182 shares of the software maker’s stock valued at $870,000 after purchasing an additional 2,826 shares in the last quarter. Finally, LS Investment Advisors LLC boosted its stake in shares of Allscripts Healthcare Solutions by 16.8% during the second quarter. LS Investment Advisors LLC now owns 14,925 shares of the software maker’s stock valued at $190,000 after purchasing an additional 2,150 shares in the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.